FOR IMMEDIATE RELEASE
MEDIA CONTACT: Hollis Templeton, Vice President, Stephen Donnelly & Associates | firstname.lastname@example.org
PRISM.science Launches Revolutionary AI-Powered Literature Surveillance Solution
AE Alert aggregates the adverse event data pharmaceutical companies need to keep patients safe.
Los Angeles, CA (February 13, 2023)— PRISM.science, the world’s most extensive and powerful biomedical database, announced today a new adverse event detection product that surpasses the shortcomings of conventional pharmacovigilance literature surveillance. AE Alert provides exhaustive global literature surveillance, monitors and aggregates all content in real-time, and delivers an intuitive interface plus powerful analytics and email alerts. The solution allows pharmaceutical and biotech companies to reduce risks and improve patient outcomes.